Xiaorong Chen

Title: Innovations of Xiaorong Chen in the Field of Biotechnology.

Introduction

Xiaorong Chen is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of novel DNA molecules. His work focuses on human CLAX proteins, which have important implications for medical research and treatment.

Latest Patents

Xiaorong Chen holds 1 patent related to DNA molecules encoding human CLAX proteins and their soluble fusion proteins. This patent provides isolated novel cDNA sequences encoding a human C-type lectin and three homologues, collectively referred to as "CLAX" (C-type Lectin, Activation Expressed) proteins. The invention includes methods for utilizing these nucleic acid sequences, polypeptides, fusion proteins, antibodies specific for the novel CLAXs, as well as ligands and inhibitors. The genes of CLAX are specifically expressed in lymphoid tissues and activated T lymphocytes, but not in resting T lymphocytes. This invention has potential applications in pharmaceutical compositions for the prevention and treatment of infectious, inflammatory, and allergic diseases.

Career Highlights

Xiaorong Chen is currently associated with Bristol-Myers Squibb Company, where he continues to advance his research in biotechnology. His work has garnered attention for its innovative approach to understanding and utilizing CLAX proteins in medical applications.

Collaborations

Xiaorong Chen collaborates with esteemed colleagues, including Guchen Yang and Patricia M Davis, who contribute to his research endeavors. Their combined expertise enhances the potential impact of their work in the field.

Conclusion

Xiaorong Chen's innovative contributions to biotechnology, particularly through his patent on CLAX proteins, highlight the importance of research in developing new therapeutic strategies. His work exemplifies the intersection of science and medicine, paving the way for advancements in treating various diseases.